Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Galenica AG ( (CH:GALE) ) has provided an announcement.
Galenica AG has successfully placed a CHF 250 million fixed-interest bond with a 7-year term and a 1.08% annual coupon. The proceeds will be used to repay bridge financing for the acquisition of the Labor Team Group and for general corporate purposes, helping to reduce short-term liabilities and secure long-term financing. This move strengthens Galenica’s financial position and complements its existing bonds, with the issuance led by UBS and an application for trading on the SIX Swiss Exchange.
The most recent analyst rating on (CH:GALE) stock is a Buy with a CHF95.00 price target. To see the full list of analyst forecasts on Galenica AG stock, see the CH:GALE Stock Forecast page.
More about Galenica AG
Galenica AG is a prominent player in the Swiss healthcare market, offering a wide range of services including pharmacies, pharmaceutical logistics, and home care. With approximately 8,000 employees, the company is dedicated to enhancing the health and well-being of people in Switzerland. Galenica is listed on the Swiss stock exchange and is committed to shaping the future of the healthcare system through strong partnerships and a diverse skill set.
Average Trading Volume: 83,783
Technical Sentiment Signal: Buy
Current Market Cap: CHF4.29B
Learn more about GALE stock on TipRanks’ Stock Analysis page.